Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(3-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenyl)acetonitrile | - |
Homo sapiens | |
(3-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenyl)methanol | - |
Homo sapiens | |
(3-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]phenyl)acetonitrile | 41% inhibition at 0.01 mM | Homo sapiens | |
(4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenyl)acetonitrile | - |
Homo sapiens | |
(4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]phenyl)acetonitrile | - |
Homo sapiens | |
4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-benzenesulfonamide | - |
Homo sapiens | |
4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-N-(2,3-dihydroxypropyl)-benzenesulfonamide | - |
Homo sapiens | |
4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-N-(2-hydroxyethyl)benzenesulfonamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N,N-diethylbenzamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N,N-diethylbenzenesulfonamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N,N-dimethylbenzamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N-(2-hydroxypropyl)benzenesulfonamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N-(tetrahydrofuran-2-ylmethyl)benzenesulfonamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N-1,3-thiazol-2-ylbenzenesulfonamide | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenol | - |
Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]-N,N-diethylbenzamide | 29% inhibition at 0.001 mM | Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]-N,N-diethylbenzenesulfonamide | 33% inhibition at 0.01 mM | Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]-N,N-dimethylbenzamide | 49% inhibition at 0.1 mM | Homo sapiens | |
4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]benzamide | - |
Homo sapiens | |
6-(cyclohexylmethoxy)-N2-(3-methoxyphenyl)-5-nitrosopyrimidine-2,4-diamine | - |
Homo sapiens | |
6-(cyclohexylmethoxy)-N2-(4-methoxyphenyl)-5-nitrosopyrimidine-2,4-diamine | - |
Homo sapiens | |
6-(cyclohexylmethoxy)-N2-[3-(methylsulfanyl)phenyl]-5-nitrosopyrimidine-2,4-diamine | - |
Homo sapiens | |
6-(cyclohexylmethoxy)-N2-[3-(methylsulfanyl)phenyl]pyrimidine-2,4-diamine | - |
Homo sapiens | |
6-(cyclohexylmethoxy)-N2-[4-(methylsulfanyl)phenyl]-5-nitrosopyrimidine-2,4-diamine | - |
Homo sapiens | |
N2-(3-bromophenyl)-6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine | - |
Homo sapiens | |
N2-(3-bromophenyl)-6-(cyclohexylmethoxy)pyrimidine-2,4-diamine | - |
Homo sapiens | |
NU2058 | - |
Homo sapiens | |
NU6027 | - |
Homo sapiens | |
NU6102 | highly potent and selective ATP-competitive inhibitor of CDK2 | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + histone H1 | - |
Homo sapiens | ADP + phosphorylated histone H1 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CDK2 | - |
Homo sapiens |
cyclin-dependent kinase 2 | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
cyclin A | cofactor of CDK2 | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000006 | - |
NU6102 | - |
Homo sapiens | |
0.0013 | - |
NU6027 | - |
Homo sapiens | |
0.012 | - |
NU2058 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000007 | - |
- |
Homo sapiens | 4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-N-(2-hydroxyethyl)benzenesulfonamide | |
0.0000008 | - |
- |
Homo sapiens | 4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-N-(2,3-dihydroxypropyl)-benzenesulfonamide | |
0.000001 | - |
- |
Homo sapiens | 4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-benzenesulfonamide | |
0.0000013 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N-(2-hydroxypropyl)benzenesulfonamide | |
0.0000022 | - |
- |
Homo sapiens | NU6027 | |
0.0000081 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N-(tetrahydrofuran-2-ylmethyl)benzenesulfonamide | |
0.000016 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenol | |
0.000019 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N-1,3-thiazol-2-ylbenzenesulfonamide | |
0.000034 | - |
- |
Homo sapiens | 4-(6-amino-4-cyclohexylmethoxy-5-nitrosopyrimidin-2-ylamino)-N-(2,3-dihydroxypropyl)-benzenesulfonamide | |
0.000045 | - |
with isozyme CDK2 | Homo sapiens | (3-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenyl)methanol | |
0.000064 | - |
with isozyme CDK2 | Homo sapiens | (4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenyl)acetonitrile | |
0.00008 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N,N-dimethylbenzamide | |
0.000086 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N,N-diethylbenzenesulfonamide | |
0.00012 | - |
with isozyme CDK2 | Homo sapiens | 6-(cyclohexylmethoxy)-N2-[4-(methylsulfanyl)phenyl]-5-nitrosopyrimidine-2,4-diamine | |
0.0002 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]-N,N-diethylbenzamide | |
0.000215 | - |
- |
Homo sapiens | 6-(cyclohexylmethoxy)-N2-(4-methoxyphenyl)-5-nitrosopyrimidine-2,4-diamine | |
0.00034 | - |
with isozyme CDK2 | Homo sapiens | 6-(cyclohexylmethoxy)-N2-(3-methoxyphenyl)-5-nitrosopyrimidine-2,4-diamine | |
0.0004 | - |
with isozyme CDK2 | Homo sapiens | 6-(cyclohexylmethoxy)-N2-[3-(methylsulfanyl)phenyl]-5-nitrosopyrimidine-2,4-diamine | |
0.0005 | - |
with isozyme CDK2 | Homo sapiens | N2-(3-bromophenyl)-6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine | |
0.024 | - |
with isozyme CDK2 | Homo sapiens | (4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]phenyl)acetonitrile | |
0.026 | - |
with isozyme CDK2 | Homo sapiens | N2-(3-bromophenyl)-6-(cyclohexylmethoxy)pyrimidine-2,4-diamine | |
0.033 | - |
with isozyme CDK2 | Homo sapiens | (3-[[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino]phenyl)acetonitrile | |
0.059 | - |
with isozyme CDK2 | Homo sapiens | 4-[[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino]benzamide | |
0.06 | - |
with isozyme CDK2 | Homo sapiens | 6-(cyclohexylmethoxy)-N2-[3-(methylsulfanyl)phenyl]pyrimidine-2,4-diamine |